Please login to the form below
ViroPharma
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ViroPharma's 2013 immunology sales performance.
Cinryze IFR toolkit
Viropharma with support from Havas Life Medicom. Cinryze was launched in March 2012 as the only licensed treatment for routine prevention of Hereditary Angioedema (HAE) attacks with no supporting NICE guidance ... Cinryze IFR toolkit - Viropharma with
The moving parts of orphan drug development
bolted on Viropharma in a $4.2bn deal announced last November.
Shire spells out why AbbVie takeover is a bad idea
of its $4.2bn acquisition of Viropharma in January.
Pharma deals during May 2014
Shire is really motoring. It acquired Viropharma last November for $4.2bn which contributed $93m of sales in the first quarter of this year.
Shire boosts rare disease portfolio with $260m Lumena deal
bolted on Viropharma in a $4.2bn deal announced last November.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis
- FDA approves two cell-based gene therapies for sickle cell disease
- Pfizer’s Elrexfio granted EC approval for relapsed and refractory multiple myeloma
- New economic data reveals risk of disincentivising UK life sciences growth
- WHO countries hold seventh INB meeting to prevent global pandemics
- The start of a beautiful friendship
No results were found
PMHub
Medscape Education Global
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....
Latest intelligence
- Virtual care – negotiating barriers to adoption offers glimpses of an exciting future
- Digital tools and innovative healthcare promise to address pressing healthcare issues if they can satisfy concerns over access, security and affordability...
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
